The company has currently applied for more than 130 invention patents and authorized 54 patents; Under the leadership of Academician Wang Guangji, the chief scientist of the company, we have established the "New Drug Release Technology Research and Development" Hefei Luzhou Industrial Innovation Team and the Jianghuai Silicon Valley Innovation and Entrepreneurship Team; Established two GMP production platforms, Sprui Pharmaceutical and Onofi Pharmaceutical; It has successfully broken through the core technology of osmotic pump preparations, overcome the core technical barriers of its preparation research and development and industrial production, mastered the key technologies of industrialization, and successfully developed venlafaxine osmotic pump controlled release tablets. In 2020, it was approved and put on the market. It is a high-end preparation that passed the consistency evaluation in our province, and won the bid for the fifth batch of national centralized drug procurement. In the later period, nearly 10 osmotic pump controlled release preparations were successively listed in China, It will bring significant economic and social benefits. The development of Huafang Pharmaceuticals has received care and support from governments at all levels such as Hefei City and Hefei National High tech Zone, striving to be listed on the internal medicine innovation board within three years and making contributions to the development of high-end drugs in China.

Our company aims to seek development, strengthen strength, expand scale, and create a brand. Adhering to the corporate philosophy of "technological innovation, people-oriented", we warmly welcome universities, research institutes, and pharmaceutical production enterprises to join forces with our company, complement each other's advantages, and establish a win-win cooperation relationship.

Culture